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A radical addition/cyclization of diverse ethers to
2-isocyanobiaryls under mildly basic aqueous
conditions†
Cintia Anton-Torrecillas, Diego Felipe-Blanco and Jose C. Gonzalez-Gomez*
Mildly basic aqueous conditions facilitated the tert-butyl peroxybenzoate (TBPB) mediated dehydrogena-
tive addition of a range of ethers, including acetals, to diverse substituted 2-isocyanobiaryls. Mechanistic
studies suggest that this radical cascade is an example of base promoted homolytic aromatic substitution
(BHAS).
Introduction
Phenanthridine is the scaﬀold of many naturally occurring
products1 that exhibit a wide range of bioactivities, such as
antitumor,2 antituberculosis,3 antimicrobial,4 antiviral,5 acari-
cidal,6 and fungicidal activities.7 Some phenanthridine deriva-
tives have also found application in biological chemistry as
dyes for cytofluorometric assays8 or even in materials science
due to their optoelectronic properties.9 Recently, the assembly
of the phenanthridine framework has been elegantly achieved
with a cascade that involves the addition of radicals to somo-
philic 2-isocyanobiphenyls, followed by intramolecular homo-
lytic aromatic substitution.10,11 In this context, and given the
progress made in the Cα–H oxidation of ethers with peroxides
to form radicals,12 the oxidative addition of ethers to
2-isocyanobiphenyls has been successfully achieved using
diﬀerent conditions.13 This transformation requires a dual
selective C–H bond functionalization, and constitutes a power-
ful tool to increase molecular complexity with high atom-
economy, where only hydrogen is lost (Scheme 1). Moreover,
ethers are very important raw materials and they are also
common substructures of natural and synthetic bioactive
products.14 Consequently, the development of methods that
make use of relatively unreactive ethers to build complex mole-
cules, is highly demanded by organic and medicinal chemists.
It is worth noting that 1,4-dioxane is the model substrate
for C–H bond functionalization of ethers in most of the
reported studies.13 This symmetric ether presents all eight
C–H bonds adjacent to an oxygen atom, which stabilizes the
radical by hyperconjugation with the non-bonding electrons.
Moreover, theoretical studies suggest that the release of ring
strain upon radical formation is greater in 1,4-dioxane than in
other cyclic ethers such as tetrahydrofuran.15 As a matter of
fact, when TBPB was used as the oxidant in the insertion of
2-isocyanobiaryls with ethers, only 1,4-dioxane was successful
and THF failed.13a Notably, when benzoyl peroxide was used
in the same transformation, another three ethers could be
inserted with moderate results (40–45%).13b To the best of our
knowledge, the greatest number of ethers tolerated in this reac-
tion (seven examples) has been possible with the use of DTBP
as the oxidant, FeCl3 as the catalyst and DBU as the co-
catalyst.13c With these precedents we decided to develop a new
protocol for this reaction aimed at accommodating a range of
ethers, free of transition-metal catalysts and using economical
and environmentally friendly conditions (Scheme 2).
Results and discussion
To explore new reaction conditions we selected 2-isocyanobi-
phenyl (1a) and THF (2a) as model substrates. In a control
experiment we performed the reaction using BPO as the
oxidant at 100 °C and we obtained 35% yield of the desired
Scheme 1 Oxidative addition of 1,4-dioxane to 2-isocyanobiphenyls:
a radical cascade.
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product 3aa, a similar result to the one obtained by the Cheng
group,13b together with byproduct 4a (Table 1, entry 1).
Surprisingly, the addition of K2CO3 and H2O completely inhi-
bited the formation of 3aa (entry 2). Prompted by the excellent
results in oxidative transformations achieved with Bu4NI as the
catalyst and TBHP,16 we tried this combination, but 3aa was
obtained in low yield (entry 3). The use of DTBP or (NH4)2S2O8
in combination with Bu4NI was also unsuccessful in this trans-
formation (entries 4–6). It is reported that TBPB fails to aﬀord
product 3aa in this reaction and that only compound 4a is
obtained.13a To our surprise, the inclusion of H2O in this reac-
tion mixture aﬀorded product 3aa, although in low yield (entry
7). We were pleased to find that the same oxidant, but in the
presence of K2CO3 and H2O, allowed full conversion of 1a to
obtain compound 3aa in good yield (entry 10). While the
addition of Bu4NI had no important impact on the reaction,
the amount of base and the control of the reaction tempera-
ture were crucial to obtain good and reliable results (entries
8–11). Similar results were obtained with Na2HPO4, and lower
yields were obtained for the desired product when non-nucleo-
philic organic bases were used in substoichiometric amounts
(entries 12–14).
Having found very simple optimized conditions for the
model reaction, we evaluated its scope using diﬀerent 2-isocyano-
biaryls and THF (Scheme 3). We first examined substrates
with substituents on the upper aromatic ring. Methyl-substi-
tuted products 3ba and 3ca were obtained in good to moderate
yields, without observing any benzylic oxidation. During the
formation of 3ca, some compound 3aa was also observed
(GC-MS), likely by ipso-homolytic aromatic substitution, and
its isolated yield was aﬀected due to diﬃculties in the chroma-
tographic purification. A more electron-donating group such
as methoxy was compatible with this protocol, aﬀording com-
pound 3da in reasonably good yield, as well as the corres-
ponding byproduct 4d (detected by GC-MS and 1H-NMR).
Scheme 2 Previous results and our reaction conditions for THF.
Scheme 3 Scope of 2-isocyanobiaryls with THF. aMeasured tempera-
ture of the sand bath. b Yields after puriﬁcation of isolated products and
in parentheses are yields of 6-H phenanthridines 4 estimated by GC-MS
of crude reaction mixtures. c Product 3aa was also formed and puriﬁ-
cation of 3ca was more diﬃcult. *The other regioisomer isolated (3’).
Table 1 Screening of reaction conditions
Entry
Oxidant (mol%)/
additive (mol%) Base (mol%)
Conv.a
(%) (3aa : 4a)b
1c BPO (120) None 100 35 : 22
2 BPO (120) K2CO3 (150) 37 —
3 TBHP (300)/Bu4NI (20) K2CO3 (150) 45 20 : 5
4 DTBP (300)/Bu4NI (20) None 0 —
5 DTBP (300)/Bu4NI (20) K2CO3 (150) 0 —
6 (NH4)2S2O8 (220) K2CO3 (150) 0 —
7 TBPB (220) None 100 12 : 4c
8 TBPB (120)/Bu4NI (20) K2CO3 (150) 55 —
9 TBPB (220) K2CO3 (100) 70 —
10d TBPB (220) K2CO3 (150) 100 77 : 23
11 TBPB (220)/Bu4NI (50) K2CO3 (150) 100 75 : 25
12 TBPB (220) Na2HPO4 (150) 90 75 : 25
13c TBPB (220) DABCO (50) 100 18 : 0
14c TBPB (220) DBU (50) 100 40 : 0
a By GC of the crude reaction mixture. b Yield calculated by 1H-NMR of
the crude reaction mixture using durene as the internal standard.
c Formation of other products is observed by GC. d The conversion was
90% at 80 °C and 0% at 60 °C. BPO = benzoyl peroxide. DTBP = di-tert-
butylperoxide. TBPB = tert-butylperoxybenzoate. DABCO = 1,4-diazabi-
cyclo[2.2.2]octane. DBU = 1,8-diazabicyclo[5.4.0]undec-7-ene.
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When 2-(2-isocyanophenyl)-naphthalene was used, compound
3ea was the only regioisomer isolated in moderate yield,
despite the steric hindrance between the ether moiety and the
extra aromatic ring.17 Electron-withdrawing groups, such as
acetyl, trifluoromethyl, chloro and fluoro, were suitable substi-
tuents in the upper aromatic ring, furnishing products (3fa,
3ga, 3ha and 3ia) in good isolated yields. Interestingly, when
meta-substituted substrates 1j and 1k were used, both possible
regioisomers were isolated after column chromatography.
While the ratio of 3ja/3′ja was 1 : 1, for 1k the major product
was the most crowded regioisomer (3ka).18 We also examined
isocyanobiaryls substituted in the lower aromatic ring by elec-
tron-donating and electron-withdrawing groups, obtaining uni-
formly moderate yields in all cases (3la–3oa).
We further explore the performance of diﬀerent ethers
using the optimized procedure (Scheme 4). 1,4-Dioxane (2b)
and THP (2c) were also suitable for this protocol, obtaining
products 3ab and 3ac in moderate yields after purification, as
well as compound 4a as the byproduct. With THP, minor
amounts of regioisomers were formed (see the ESI† for GC-MS
of isomers), complicating the isolation of 3ac in a pure form.
Acyclic ethers such as i-Pr2O (2d), n-Bu2O (2e) and t-BuOMe
(2g) aﬀorded the corresponding products in good to excellent
yields, with linear n-Bu2O providing the best yield. 2-MeTHF
(2f ) was also examined, aﬀording the more substituted com-
pound 3af as the major product and regioisomer 3′af as an
inseparable trans/cis mixture. Surprisingly, when Bn2O (2h)
was examined, the expected product (3ah) was obtained in
only 17% yield and the addition of a benzyl radical took place
preferentially (3′ah). It seems reasonable that after
H-abstraction from Bn2O, a β-fragmentation gives rise to the
benzyl radical, which is finally added to 1a. The addition of
phthalan (2i) was also possible, but compound 3ai was
obtained in lower yield. Importantly, acetals 2j and 2k led,
respectively, to products 3aj and 3ak in synthetically useful
yields. These compounds could be easily hydrolyzed to obtain
the corresponding 6-formylphenanthridine and the acetal
moiety has the potential to be transformed into other
functionalities.19
Investigation of the reaction mechanism
To gain insight into the reaction mechanism we performed
some experiments. As shown in Scheme 5a, the use of TEMPO
as a radical scavenger in our model reaction, under standard
conditions, completely inhibited the formation of 3aa and the
coupling product 5 was detected by MS. Since compounds 4
are consistent byproducts of the radical cyclization studied
here, we were intrigued about their formation and we have not
found any experimental evidence of this in the literature.20
When the reaction was conducted using D2O and D8-THF
(Scheme 5b), the expected product D7-3aa was obtained,
Scheme 4 Scope of ethers. aMeasured temperature of the sand bath.
b Yields after puriﬁcation of isolated products and in parentheses are
yields of 4a. Scheme 5 Mechanistic investigations.
Paper Organic & Biomolecular Chemistry
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accompanied by phenanthridine 4a. Importantly, the bypro-
duct of this reaction is not deuterated, indicating that neither
THF nor H2O is the source of hydrogen for the formation of
this phenanthridine. We also studied the intermolecular
kinetic isotopic eﬀect (KIE) by competition experiments of
equimolar amounts of THF and D8-THF with 1a at the initial
stage of the reaction (Scheme 5c). The large KIE obtained
(kH/kD = 3.16) suggests that the cleavage of the C(sp
3)–H bond
is involved in the rate determining step of this reaction. In
addition, we also performed competition experiments at the
initial state of the reaction, using equimolar quantities of 1a
and 2-isocyanobiphenyls substituted in position 4′ by methyl
or fluoro groups. The results shown in Scheme 4d suggested
that electron-withdrawing substituents in the upper aromatic
ring accelerate the reaction. Since this class of group stabilizes
the LUMO of the upper aromatic ring, this result is also con-
sistent with a radical cyclization pathway.21
An important feature of this protocol is the crucial role of
K2CO3 and H2O in a successful transformation (Table 1,
entries 6 and 9). Since the seminal contribution of Studer and
Curran,22 several known reactions have been recognized as
“base promoted homolytic substitutions” (BHAS) and many
new transformations have been developed with this concept.11
Based on literature precedents and our own results, we believe
that this reaction is an example of BHAS. A possible reaction
mechanism is depicted in Scheme 6. Firstly, homolysis of
TBPB takes place upon heating. From the two generated rad-
icals, it is reported that t-BuO• abstracts a hydrogen atom from
THF faster than Bz•·to generate the α-furanyl radical.23
Addition of this intermediate to isonitrile 1a, followed by intra-
molecular addition to the upper aromatic ring, is well docu-
mented in a number of examples.11 DFT studies performed by
the Studer group indicate that cyclohexadienyl radicals, such
as I, are extremely strong acids (pKa ∼ −15 in H2O).24
Therefore, this radical intermediate can be deprotonated
under mild basic aqueous conditions (e.g. K2CO3 in H2O) to
generate a radical anion II. This species is a potent reductant
that can easily transfer an electron to radical Bz• or to oxidant
TBPB, while generating product 3aa. In addition, intermediate
I can transfer a hydrogen atom to 1a, which after a similar
BHAS process leads to the formation of byproduct 4a. This
explanation is consistent with our observation that neither
THF nor H2O was the hydrogen source of 4a.
25
Conclusions
In conclusion, we have demonstrated that TBPB can be used
under mildly basic aqueous conditions to promote the radical
addition of a range of ethers to 2-isocyanobiaryls followed by
cyclization. Mechanistic investigations suggest that this trans-
formation is an example of BHAS and a plausible explanation
is provided for the formation of byproduct 4. Some salient fea-
tures of the developed methodology are: (a) neither transition
metals nor any expensive additives are needed; (b) the wastes
generated are harmless inorganic salts and can be easily
removed by aqueous workup; (c) the reaction medium is con-
stituted by the reactant ethers and water.
Experimental section
General remarks
All starting isonitriles were prepared according to a reported
method.10b TLC was performed on silica gel 60 F254, using alu-
minium plates and visualized by exposure to ultraviolet light.
Flash chromatography was carried out on hand-packed
columns of silica gel 60 (230–400 mesh). Infrared (IR) spectra
were recorded with a spectrophotometer equipped with an
ATR component; wavenumbers are given in cm−1. LRMS were
obtained using a mass spectrometer coupled with a gas chro-
matographer (GC); the mobile phase was helium (2 mL
min−1); HP-1 column of 12 m was used; temperature program
starts at 80 °C for 3 min, then up to 270 °C at a rate of 20 °C
min−1, and 17.5 min at 270 °C. HRMS analyses were carried
out using Electron Impact (EI) mode at 70 eV by Q-TOF.
1H NMR spectra were recorded at 300 or 400 MHz for 1H-NMR
and 75 or 100 MHz for 13C-NMR, using CDCl3 as the solvent
and TMS as an internal standard (0.00 ppm). The data are
being reported as (s = singlet, d = doublet, t = triplet, m =
multiplet or unresolved, br s = broad signal, coupling
constant(s) in Hz, integration). 13C-NMR spectra were recorded
with 1H-decoupling at 100 MHz and referenced to CDCl3 at
77.16 ppm. DEPT-135 experiments were performed to assign
CH, CH2 and CH3.
General procedure for the synthesis of compounds 3
Into a pressure tube were added K2CO3 (103 mg, 0.75 mmol)
and H2O (0.82 mL). Then, to it were added sequentially the
2-isocyanobiaryl derivative 1 (0.50 mmol), ether 2 (2.5 mL) and
tert-butyl peroxibenzoate (TBPB) (213 µL, 1.10 mmol). The
reaction mixture was stirred under an Ar atmosphere for
12–14 h at 110 °C (sand bath temperature). Upon full conver-Scheme 6 Plausible mechanism.
Organic & Biomolecular Chemistry Paper
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sion of the isonitrile (TLC or GC), a saturated solution of
NaHCO3 (5 mL) and EtOAc (10 mL) was added to the reaction
mixture. After phase separation, the aqueous phase was
extracted with EtOAc (3 × 15 mL) and the combined organic
layers were washed with brine (5 mL), dried over MgSO4 and
concentrated under reduced pressure. The residue was purified
by flash column chromatography on silica gel to give the
desired product.
6-(Tetrahydrofuran-2-yl)phenanthridine (3aa).13c Following
the general procedure, compound 3aa was obtained after
column chromatography (hexane/EtOAc 9 : 1) as a yellow pale
solid (91 mg, 0.36 mmol, 73%): Rf 0.23 (95 : 5 hexane/EtOAc);
1H-NMR (300 MHz, CDCl3) δ 8.63 (dd, J = 8.2, 1.3 Hz, 1H), 8.55
(dd, J = 8.0, 1.5 Hz, 1H), 8.45 (dd, J = 8.7, 1.0 Hz, 1H), 8.19 (dd,
J = 7.9, 1.6 Hz, 1H), 7.83 (ddd, J = 8.3, 7.0, 1.3 Hz, 1H),
7.75–7.61 (m, 3H), 5.78 (t, J = 6.9 Hz, 1H), 4.26–4.15 (m, 1H),
4.13–4.01 (m, 1H), 2.82–2.65 (m, 1H), 2.50–2.35 (m, 1H),
2.30–2.03 (m, 2H) ppm; 13C-NMR (101 MHz, CDCl3) δ 159.4
(C), 143.4 (C), 133.4 (C), 130.6 (CH), 130.4 (CH), 128.6 (CH),
127.3 (CH), 127.0 (CH), 126.6 (CH), 124.9 (C), 124.2 (C), 122.5
(CH), 122.0 (CH), 79.7 (CH), 69.1 (CH2), 30.1 (CH2), 26.1 (CH2)
ppm; IR ν 3073, 2981, 2881, 1583, 1444, 1300, 1057, 727 cm−1;
LRMS (EI) m/z (%) = 249 (M+, 5), 220 (15), 206 (100), 193 (48),
178 (15).
8-Methyl-6-(tetrahydrofuran-2-yl)phenanthridine (3ba).
Following the general procedure, compound 3ba was obtained
after column chromatography (hexane/EtOAc 93 : 7) as a yellow
pale solid (80 mg, 0.31 mmol, 61%): Rf 0.20 (93 : 7 hexane/
EtOAc); 1H-NMR (400 MHz, CDCl3) δ 8.54–8.48 (m, 2H), 8.20 (br
s, 1H), 8.16 (dd, J = 8.1, 1.1 Hz, 1H), 7.71–7.59 (m, 3H), 5.79–5.74
(m, 1H), 4.23–4.15 (m, 1H), 4.10–4.03 (m, 1H), 2.83–2.72 (m,
1H), 2.60 (s, 3H), 2.46–2.35 (m, 1H), 2.27–2.17 (m, 1H), 2.17–2.06
(m, 1H) ppm; 13C-NMR (101 MHz, CDCl3) δ 159.0 (C), 143.1 (C),
137.2 (C), 132.1 (CH), 131.2 (C), 130.5 (CH), 128.1 (CH), 126.9
(CH), 126.0 (CH), 125.1 (C), 124.3 (C), 122.3 (CH), 121.8 (CH),
79.5 (CH), 69.1 (CH2), 30.0 (CH2), 26.1 (CH2), 22.1 (CH3) ppm;
IR ν 2955, 2867, 1577, 1460, 1052, 760 cm−1; LRMS (EI)
m/z (%) = 263 (M+, 6), 234 (10), 220 (100), 207 (57); HRMS (EI)
m/z calcd for C18H17NO 263.1310, found 263.1307.
10-Methyl-6-(tetrahydrofuran-2-yl)phenanthridine (3ca).
Following the general procedure, compound 3ca was obtained
after column chromatography (hexane/EtOAc 95 : 5–9 : 1) as a
yellow pale solid (54 mg, 0.20 mmol, 41%): Rf 0.20
(95 : 5 hexane/EtOAc); 1H-NMR (300 MHz, CDCl3) δ 8.77 (br d,
J = 8.2 Hz, 1H), 8.35 (dd, J = 8.1, 1.6 Hz, 1H), 8.23 (dd, J = 8.1,
1.5 Hz, 1H), 7.70 (ddd, J = 8.2, 7.0, 1.4 Hz, 1H), 7.67–7.55 (m,
3H), 5.81–5.75 (t, J = 6.8 Hz, 1H), 4.25–4.15 (m, 1H), 4.10–4.01
(m, 1H), 3.11 (s, 3H), 2.84–2.67 (m, 1H), 2.48–2.32 (m, 1H),
2.27–2.00 (m, 2H) ppm; 13C-NMR (101 MHz, CDCl3) δ 159.6 (C),
144.5 (C), 135.6 (C), 134.6 (CH), 132.9 (C), 130.9 (CH),
127.8 (CH), 126.7 (CH), 126.5 (CH), 126.4 (C), 126.1 (CH), 125.6 (C),
124.9 (CH), 79.7 (CH), 69.1 (CH2), 30.1 (CH2), 27.1 (CH2),
26.1 (CH3) ppm; IR ν 3069, 2968, 2871, 1587, 1437, 1054,
760 cm−1; LRMS (EI) m/z (%) = 263 (M+, 8), 234 (18), 220 (100),
207 (59), 204 (21), 165 (18); HRMS (EI) m/z calcd for C18H17NO
263.1310, found 263.1306.
8-Methoxy-6-(tetrahydrofuran-2-yl)phenanthridine (3da).
Following the general procedure, compound 3da was obtained
after column chromatography (hexane/EtOAc 95 : 5–75 : 25) as
a white solid (78 mg, 0.28 mmol, 55%): Rf 0.20 (9 : 1 hexane/
EtOAc); 1H-NMR (300 MHz, CDCl3) δ 8.53 (d, J = 9.1 Hz, 1H),
8.47–8.41 (m, 1H), 8.17–8.12 (m, 1H), 7.82 (d, J = 2.6 Hz, 1H),
7.68–7.56 (m, 2H), 7.44 (dd, J = 9.1, 2.6 Hz, 1H), 5.69 (t, J = 6.9
Hz, 1H), 4.24–4.12 (m, 1H), 4.12–4.01 (m, 1H), 3.98 (s, 3H),
2.87–2.71 (m, 1H), 2.47–2.32 (m, 1H), 2.28–2.05 (m, 2H) ppm;
13C-NMR (101 MHz, CDCl3) δ 158.6 (C), 158.4 (C), 142.5 (C),
130.5 (CH), 127.8 (C), 127.6 (CH), 127.0 (CH), 126.3 (C), 124.3 (C),
124.1(CH), 121.5 (CH), 120.8 (CH), 107.1 (CH), 80.1 (CH),
69.1 (CH2), 55.6 (CH3), 29.8 (CH2), 26.2 (CH2) ppm; IR ν 3000,
2964, 2858, 1571, 1059, 754 cm−1; LRMS (EI) m/z (%) = 279
(M+, 12), 250 (8), 236 (100), 223 (44), 207 (35); HRMS (EI) m/z
calcd for C18H17NO2 279.1259, found 279.1261.
5-(Tetrahydrofuran-2-yl)benzo[i]phenanthridine (3ea).
Following the general procedure, compound 3ea was obtained
after column chromatography (hexane/EtOAc 98 : 2–95 : 5) as a
white solid (57 mg, 0.19 mmol, 38%): Rf 0.35 (96 : 4 hexane/
EtOAc); 1H-NMR (400 MHz, CDCl3) δ 9.19 (H-1, d, J = 8.5 Hz,
1H), 8.57 (H-12 + H-4, dd, J = 8.7, 5.2 Hz, 2H), 8.23 (H-7, dd, J =
8.2, 1.1 Hz, 1H), 8.10 (H-11, d, J = 8.9 Hz, 1H), 7.98 (H-10, d, J =
7.9 Hz, 1H), 7.78–7.71 (H-2 + H-8, m, 2H), 7.68–7.63 (H-3 +
H-9, m, 2H), 5.91 (H-2′, t, J = 6.4 Hz, 1H), 4.47–4.38 (H-5′, m,
1H), 4.20–4.13 (H-5′, m, 1H), 2.99–2.86 (H-3′, m, 1H), 2.59–2.37
(H-4′, m, 1H), 2.27–2.07 (H-3′ + H-4′, m, 2H) ppm; 13C-NMR
(101 MHz, CDCl3) δ 157.7 (C), 144.0 (C), 133.8 (C), 133.2 (C),
131.9(C), 130.1 (CH), 129.9 (C), 128.8 (CH), 128.7 (CH), 128.4
(CH), 127.2 (CH), 126.9 (CH), 126.7 (CH), 123.7(C), 123.0 (C),
122.5 (CH), 120.2 (CH), 80.5 (CH), 69.4 (CH2), 31.3 (CH2), 26.8
(CH2) ppm; IR ν 3019, 2961, 2937, 1561, 1465, 1350, 1051,
750 cm−1; LRMS (EI) m/z (%) = 299 (M+, 14), 256 (100),
242 (28), 227 (19); HRMS (EI) m/z calcd for C21H17NO
299.1310, found 299.1304.
1-(6-(Tetrahydrofuran-2-yl)phenanthridin-8-yl)ethan-1-one (3fa).
Following the general procedure, compound 3fa was obtained
after column chromatography (hexane/EtOAc 8 : 2) as a yellow
pale solid (77 mg, 0.27 mmol, 53%): Rf 0.20 (8 : 2 hexane/
EtOAc); 1H-NMR (300 MHz, CDCl3) δ 9.10 (br s, 1H), 8.65 (d,
J = 8.7 Hz, 1H), 8.54 (d, J = 8.2 Hz, 1H), 8.35 (dd, 2H), 8.19 (dd,
J = 8.1, 1.2 Hz, 1H), 7.77 (ddd, J = 8.3, 7.0, 1.4 Hz, 1H), 7.67
(ddd, J = 8.3, 7.1, 1.4 Hz, 1H), 5.77 (t, J = 7.0 Hz, 1H), 4.22–4.13
(m, 1H), 4.13–4.04 (m, 1H), 2.88–2.79 (m, 1H), 2.77 (s, 3H),
2.52–2.37 (m, 1H), 2.31–2.10 (m, 2H) ppm; 13C-NMR
(101 MHz, CDCl3) δ 197.5 (C), 159.8 (C), 144.2 (C), 136.5 (C),
135.3 (C), 130.7 (C), 129.8 (CH), 128.8 (CH), 128.2 (CH), 127.4
(CH), 124.5 (C), 123.5 (C), 122.9 (CH), 122.6 (CH), 79.9 (CH),
69.2 (CH2), 29.9 (CH2), 26.9 (CH2), 26.2 (CH3) ppm; IR ν 2977,
2921, 2856, 1683, 1615, 1251, 1052, 760 cm−1; LRMS (EI) m/z
(%) = 291 (M+, 5), 263 (20), 248 (100), 235 (65), 207 (17); HRMS
(EI) m/z calcd for C19H17NO2 291.1259, found 291.1265.
6-(Tetrahydrofuran-2-yl)-8-(trifluoromethyl)phenanthridine
(3ga). Following the general procedure, compound 3ga was
obtained after column chromatography (hexane/EtOAc
95 : 5–9 : 1) as a yellow pale solid (111 mg, 0.35 mmol, 70%):
Paper Organic & Biomolecular Chemistry
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Rf 0.25 (95 : 5 hexane/EtOAc);
1H-NMR (400 MHz, CDCl3) δ 8.81
(s, 1H), 8.72 (d, J = 8.6 Hz, 1H), 8.54 (d, J = 8.1 Hz, 1H), 8.20 (d,
J = 8.1 Hz, 1H), 8.00 (d, J = 8.6 Hz, 1H), 7.78 (t, J = 7.4 Hz, 1H),
7.69 (t, J = 7.5 Hz, 1H), 5.72 (t, J = 6.9 Hz, 1H), 4.19–4.12 (m,
1H), 4.12–4.03 (m, 1H), 2.88–2.75 (m, 1H), 2.48–2.35 (m, 1H),
2.30–2.08 (m, 2H); 13C-NMR (101 MHz, CDCl3) δ 159.2 (C),
144.0 (C), 135.6 (C), 130.7 (CH), 129.8 (CH), 129.1(CH), 129.0
(C-8, d, 2JC–F = 32.4 Hz), 127.6 (CH), 126.3 (CH, q,
3JC–F =
3.3 Hz), 124.5 (CH, q, 3JC–F = 4.3 Hz), 124.4 (CH), 124.25 (d,
1JC–F = 272.2 Hz), 123.5 (CH), 123.3 (C), 122.4 (CH), 80.0 (CH),
69.2 (CH2), 29.8 (CH2), 26.2 (CH2) ppm; IR ν 2966, 2874, 1722,
1625, 1173, 1122, 763 cm−1; LRMS (EI) m/z (%) = 317 (M+, 4),
288 (8), 274 (100), 261 (73), 247 ([(M + 1)+ − THF], 14), 226 (12);
HRMS (EI) m/z calcd for C14H8F3N, 247.0609, found 247.0612.
8-Chloro-6-(tetrahydrofuran-2-yl)phenanthridine (3ha).
Following the general procedure, compound 3ha was obtained
after column chromatography (hexane/EtOAc 95 : 5) as an
orange pale solid (92 mg, 0.32 mmol, 65%): Rf 0.25
(95 : 5 hexane/EtOAc); 1H-NMR (300 MHz, CDCl3) δ 8.53 (d, J =
8.9 Hz, 1H), 8.46 (dd, J = 7.5, 1.8 Hz, 2H), 8.16 (dd, J = 8.1,
1.1 Hz, 1H), 7.78–7.68 (m, 2H), 7.64 (ddd, J = 8.4, 7.1, 1.5 Hz,
1H), 5.65 (t, J = 6.9 Hz, 1H), 4.20–4.11 (m, 1H), 4.11–4.01 (m,
1H), 2.87–2.71 (m, 1H), 2.47–2.30 (m, 1H), 2.29–2.00 (m, 2H)
ppm; 13C-NMR (101 MHz, CDCl3) δ 158.3 (C), 143.3 (C),
133.3 (C), 131.8 (C), 130.9 (CH), 130.7 (CH), 128.9 (CH),
127.4 (CH), 126.2 (CH), 126.0 (C), 124.2 (CH), 123.6 (C),
121.9 (CH), 79.8 (CH), 69.1 (CH2), 29.7 (CH2), 26.1 (CH2) ppm;
IR ν 3063, 2939, 2839, 1617, 1460, 1220, 1038, 759 cm−1; LRMS
(EI) m/z (%) = 283 (M+, 8), 254 (15), 240 ([M+ − C2H3O], 100),
217 (12), 207 (65), 177 (39); HRMS (EI) m/z calcd for C15H11ClN
240.0580, found 240.0586.
8-Fluoro-6-(tetrahydrofuran-2-yl)phenanthridine (3ia).
Following the general procedure, compound 3ia was obtained
after column chromatography (hexane/EtOAc 95 : 5–8 : 2) as a
yellow pale solid (80 mg, 0.30 mmol, 60%): Rf 0.21
(95 : 5 hexane/EtOAc); 1H-NMR (400 MHz, CDCl3) δ 8.60 (H-10,
dd, JH–F = 9.1, 5.4 Hz, 1H), 8.46 (dd, J = 8.1, 1.1 Hz, 1H), 8.17
(dd, J = 8.1, 1.2 Hz, 1H), 8.12 (H-7, dd, JH–F = 10.2, 2.6 Hz, 1H),
7.70 (ddd, J = 8.2, 7.0, 1.5 Hz, 1H), 7.64 (ddd, J = 8.3, 7.0,
1.5 Hz, 1H), 7.56 (H-9, ddd, JH–F = 9.1, 8.0, 2.7 Hz, 1H), 5.63
(H-2′, t, J = 6.9 Hz, 1H), 4.20–4.13 (H-5′, m, 1H), 4.09–4.02
(H-5′, m, 1H), 2.84–2.71 (m, 1H), 2.44–2.34 (m, 1H), 2.27–2.06
(m, 2H) ppm; 13C-NMR (101 MHz, CDCl3) δ 161.33 (C-8, d,
1JC–F = 248.0 Hz), 158.53 (C, d,
4JC–F = 4.3 Hz), 142.94 (C),
130.62 (CH), 130.11 (C), 128.51 (CH), 127.43 (CH), 126.24
(C-6a, d, 3JC–F = 7.8 Hz), 124.93 (C-10, d,
3JC–F = 8.5 Hz), 123.82 (C),
121.76 (CH), 119.64 (CH, d, 2JC–F = 23.9 Hz), 111.59 (CH, d,
2JC–F = 21.8 Hz), 80.08 (CH), 69.14 (CH2), 29.79 (CH2), 26.08
(CH2); IR ν 2958, 2873, 1773, 1697, 1480, 1196, 1054,759 cm
−1;
LRMS (EI) m/z (%) = 267.1 (M+, 5), 238 (12), 224 (100), 211 (59),
197 (19), 169 (11); HRMS (EI) m/z calcd for C17H14FNO
267.1059, found 267.1042.
7-Methyl-6-(tetrahydrofuran-2-yl)phenanthridine (3ja).
Following the general procedure, compound 3ja was obtained
after column chromatography (hexane/EtOAc 98 : 2–95 : 5) as a
yellow pale solid (38 mg, 0.14 mmol, 28%): Rf 0.16
(98 : 2 hexane/EtOAc); 1H-NMR (400 MHz, CDCl3) δ 8.53 (d, J =
8.3 Hz, 1H), 8.51 (d, J = 8.3 Hz, 1H), 8.12 (dd, J = 8.1, 1.4 Hz,
1H), 7.71–7.57 (m, 3H), 7.49 (d, J = 7.2 Hz, 1H), 5.97 (dd, J =
6.9, 5.2 Hz, 1H), 4.20–4.12 (m, 1H), 4.04–3.95 (m, 1H), 3.09 (s,
3H), 2.89–2.80 (m, 1H), 2.32–2.12 (m, 2H), 2.11–1.96 (m, 1H)
ppm; 13C-NMR (101 MHz, CDCl3) δ 159.4 (C), 142.5 (C), 136.5 (C),
134.9 (C), 132.0 (CH), 130.2 (CH), 129.6 (CH), 128.4 (CH),
126.9 (CH), 125.4 (C), 124.4 (C), 122.2 (CH), 120.9 (CH),
80.3 (CH), 68.9(CH2), 30.3 (CH2), 25.8 (CH2), 25.2 (CH3) ppm;
IR ν 2959, 2874, 1573, 1449, 1286, 1048, 749 cm−1; LRMS (EI)
m/z (%) = 263 (M+, 8), 248 (6), 234 (13), 220 (100), 207 (13),
193 (19); HRMS (EI) m/z calcd for C18H17NO 263.1310, found
263.1312.
9-Methyl-6-(tetrahydrofuran-2-yl)phenanthridine (3′ja). From
the same reaction where compound 3ja was obtained, and
after column chromatography (hexane/EtOAc 95 : 5–100%
EtOH), isomer 3′ja was isolated as a yellow pale solid (37 mg,
0.14 mmol, 28%): Rf 0.19 (95 : 5 hexane/EtOAc);
1H-NMR
(400 MHz, CDCl3) δ 8.52 (dd, J = 8.1, 1.5 Hz, 1H), 8.40 (H-10, s,
1H), 8.31 (d, J = 8.4 Hz, 1H), 8.16 (dd, J = 8.1, 1.0 Hz, 1H), 7.68
(ddd, J = 8.2, 7.1, 1.4 Hz, 1H), 7.60 (ddd, J = 8.3, 7.1, 1.4 Hz,
1H), 7.50 (dd, J = 8.4, 1.4 Hz, 1H), 5.73 (t, J = 6.9 Hz, 1H),
4.23–4.16 (m, 1H), 4.11–4.00 (m, 1H), 2.76–2.65 (m, 1H), 2.62
(s, 3H), 2.46–2.32 (m, 1H), 2.27–2.04 (m, 2H) ppm; 13C-NMR
(101 MHz, CDCl3) δ 159.3 (C), 143.6 (C), 140.7 (C), 133.5 (C),
130.5 (CH), 129.0 (CH), 128.4 (CH), 126.7 (CH), 126.4 (CH),
124.1 (C), 123.0 (C), 122.1 (CH), 121.9 (CH), 79.8 (CH), 69.1
(CH2), 30.2 (CH2), 26.1 (CH2), 22.3 (CH3) ppm; IR ν 2875, 2868,
1618, 1460, 1053, 760; LRMS (EI) m/z (%) = 263 (M+, 5),
234 (13), 220 (100), 207 (51), 192 (23); HRMS (EI) m/z calcd for
C18H17NO 263.1310, found 263.1312.
7-Fluoro-6-(tetrahydrofuran-2-yl)phenanthridine (3ka).
Following the general procedure, compound 3ka was obtained
after column chromatography (hexane/EtOAc 93 : 7) as a white
solid (51 mg, 0.19 mmol, 38%): Rf 0.19 (9 : 1 hexane/EtOAc);
1H-NMR (300 MHz, CDCl3) δ 8.49 (d, J = 8.2 Hz, 1H), 8.45 (d,
J = 8.4 Hz, 1H), 8.22 (dd, J = 8.2, 1.2 Hz, 1H), 7.82–7.70 (m,
2H), 7.64 (ddd, J = 8.3, 7.1, 1.4 Hz, 1H), 7.36 (ddd, J = 12.5, 7.9,
1.0 Hz, 1H), 6.02 (dt, J = 8.2, 4.3 Hz, 1H), 4.43–4.32 (m, 1H),
4.17–4.05 (m, 1H), 2.60–2.45 (m, 1H), 2.40–2.23 (m, 1H),
2.13–1.96 (m, 1H) ppm; 13C-NMR (75 MHz, CDCl3) δ 160.2
(C-7, d, 1JC–F = 255.2 Hz), 158.8 (C, d,
3JC–F = 7.9 Hz), 143.3
(CH), 136.0 (C, d, 4JC–F = 4.4 Hz), 131.0 (C-9, d,
3JC–F = 9.8 Hz),
130.8 (CH), 129.3 (CH), 127.3 (CH), 122.7 (C, d, 5JC–F = 2.7 Hz),
122.3 (CH), 118.7 (C-10, d, 4JC–F = 4.0 Hz), 114.2 (CH), 114.1
(CH), 114.0 (C-6a, d, 2JC–F = 24.6 Hz), 81.9 (C-2′, d,
4JC–F =
14 Hz), 69.3 (CH2), 31.7 (CH2), 25.1 (CH2) ppm; IR ν 2970,
2870, 1581, 1451, 1240, 757 cm−1; LRMS (EI) m/z (%) = 267
(M+, 2), 224 (100), 211 (64), 197 (19), 169 (9); HRMS (EI) m/z
calcd for C17H14FNO 267.1059, found 267.1050.
9-Fluoro-6-(tetrahydrofuran-2-yl)phenanthridine (3′ka).
From the same reaction where compound 3ka was obtained,
and after column chromatography (hexane/EtOAc 95 : 5),
isomer 3′ka was isolated as a white solid (24 mg, 0.09 mmol,
18%): Rf 0.27 (9 : 1 hexane/EtOAc);
1H-NMR (300 MHz, CDCl3)
δ 8.52 (H-7, dd, J = 9.1, 5.8 Hz, 1H), 8.41 (H-1, dd, J = 8.2,
Organic & Biomolecular Chemistry Paper
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1.1 Hz, 1H), 8.22 (H-10, dd, J = 10.5, 2.6 Hz, 1H), 8.17 (H-4, dd,
J = 8.3, 1.2 Hz, 1H), 7.74 (ddd, J = 8.3, 7.0, 1.5 Hz, 1H), 7.64
(ddd, J = 8.3, 7.0, 1.4 Hz, 1H), 7.42 (H-8, ddd, J = 9.1, 8.2,
2.6 Hz, 1H), 5.70 (H-2′, t, J = 6.9 Hz, 1H), 4.21–4.11 (H-5′, m,
1H), 4.10–4.01 (H-5′, m, 1H), 2.88–2.71 (m, 1H), 2.47–2.31 (m,
1H), 2.29–2.05 (m, 2H) ppm; 13C-NMR (101 MHz, CDCl3)
δ 163.70 (C-9, d, 1JC–F = 251.5 Hz); 158.7 (C), 143.6 (C), 135.9
(C-10a, d, 3JC–F = 9.4 Hz), 130.6 (CH), 129.8 (C-7, d,
3JC–F =
9.3 Hz), 129.3 (CH), 127.1 (CH), 123.8 (C-6a, d, 4JC–F = 4.1 Hz),
122.2 (CH), 122.0 (C-6, d, 5JC–F = 2 Hz), 116.3 (C-10/C-8, d,
2JC–F = 23.7 Hz), 107.5 (C-8/C-10, d,
2JC–F = 22.1 Hz), 80.0 (CH),
69.1 (CH2), 29.8 (CH2), 26.1 (CH2) ppm; IR ν 2962, 2877, 1619,
1496, 1195, 1052, 760 cm−1; LRMS (EI) m/z (%) = 267 (M+, 3),
238 (13), 224 (100), 211 (55), 197 (17), 169 (9); HRMS (EI) m/z
calcd for C17H14FNO 267.1059, found 267.1054.
2-Methyl-6-(tetrahydrofuran-2-yl)phenanthridine (3la).
Following the general procedure, but from 0.30 mmol of 1l,
compound 3la was obtained after column chromatography
(hexane/EtOAc 94 : 6–93 : 7) as a yellow pale solid (43 mg,
0.16 mmol, 55%): Rf 0.17 (93 : 7 hexane/EtOAc);
1H-NMR
(300 MHz, CDCl3) δ 8.61 (d, J = 8.3 Hz, 1H), 8.42 (dd, J = 8.3,
0.7 Hz, 1H), 8.31 (s, 1H), 8.07 (d, J = 8.3 Hz, 1H), 7.79 (ddd, J =
8.3, 7.0, 1.3 Hz, 1H), 7.66 (ddd, J = 8.3, 7.0, 1.3 Hz, 1H), 7.53
(dd, J = 8.3, 1.6 Hz, 1H), 5.74 (t, J = 6.9 Hz, 1H), 4.25–4.14 (m,
1H), 4.11–4.00 (m, 1H), 2.83–2.66 (m, 1H), 2.61 (s, 3H),
2.48–2.33 (m, 1H), 2.28–2.02 (m, 2H) ppm; 13C-NMR
(101 MHz, CDCl3) δ 158.3 (C), 141.7 (C), 136.8 (C), 133.1 (C),
130.3 (CH), 130.3 (CH), 130.1(CH), 127.1 (CH), 126.5 (CH),
125.0 (C), 124.0 (C), 122.4 (CH), 121.6 (CH), 79.8 (CH), 69.1
(CH2), 30.1 (CH2), 26.1 (CH2), 22.1 (CH3) ppm; IR ν 2971, 2923,
2867, 1582, 1496, 1295, 1051, 822, 729 cm−1; LRMS (EI)
m/z (%) = 263 (M+, 6), 234 (12), 220 (100), 207 (47), 192 (15),
165 (12); HRMS (EI) m/z calcd for C18H17NO 263.1310, found
263.1312.
6-(Tetrahydrofuran-2-yl)-2-(trifluoromethoxy)phenanthridine
(3ma). Following the general procedure, but from 0.45 mmol
of 1m, compound 3ma was obtained after column chromato-
graphy (hexane/EtOAc 94 : 6) as a red solid (84 mg, 0.25 mmol,
55%): Rf 0.20 (93 : 7 hexane/EtOAc);
1H-NMR (400 MHz, CDCl3)
δ 8.55 (d, J = 8.3 Hz, 1H), 8.48 (d, J = 7.9 Hz, 1H), 8.34 (d, J =
1.7 Hz, 1H), 8.21 (d, J = 8.9 Hz, 1H), 7.87 (ddd, J = 8.4, 7.1,
1.3 Hz, 1H), 7.75 (ddd, J = 8.3, 7.0, 1.2 Hz, 1H), 7.57 (ddd, J =
8.9, 2.6, 1.1 Hz, 1H), 5.77 (t, J = 6.9 Hz, 1H), 4.23–4.15 (m, 1H),
4.12–4.04 (m, 1H), 2.81–2.65 (m, 1H), 2.50–2.35 (m, 1H),
2.31–2.06 (m, 2H) ppm; 13C-NMR (101 MHz, CDCl3) δ 160.1
(C), 147.7 (C), 141.7 (C), 132.8 (C), 132.5 (CH), 130.7 (CH),
128.2 (CH), 126.8 (CH), 125.1 (C-2, d, 3JC–F = 10.5 Hz), 122.6
(CH), 121.9 (CH), 120.8 (q, 1JC–F = 257.5 Hz), 113.7 (CH), 79.6
(CH), 69.2 (CH2), 30.1 (CH2), 26.1 (CH2) ppm; IR ν 2964, 2860,
1619, 1587, 1492, 1254, 1214 cm−1; LRMS (EI) m/z (%) = 333
(M+, 5), 304 (24), 290 (100), 277 (51), 263 (8); HRMS (EI) m/z
calcd for C18H14F3NO2 333.0977, found 333.0950.
2-Chloro-6-(tetrahydrofuran-2-yl)phenanthridine (3na).
Following the general procedure, but from 0.30 mmol of 1n,
compound 3na was obtained after column chromatography
(hexane/EtOAc 94 : 6–93 : 7) as a white solid (42 mg,
0.15 mmol, 50%): Rf 0.20 (93 : 7 hexane/EtOAc);
1H-NMR
(300 MHz, CDCl3) δ 8.53 (d, J = 8.2 Hz, 1H), 8.48 (d, J = 2.1 Hz,
1H), 8.44 (d, J = 8.1 Hz, 1H), 8.10 (d, J = 8.7 Hz, 1H), 7.87–7.79
(m, 1H), 7.71 (ddd, J = 8.3, 7.0, 1.2 Hz, 1H), 7.64 (dd, J = 8.7,
2.3 Hz, 1H), 5.74 (t, J = 6.9 Hz, 1H), 4.24–4.14 (m, 1H),
4.11–4.01 (m, 1H), 2.79–2.65 (m, 1H), 2.49–2.34 (m, 1H),
2.28–2.03 (m, 2H) ppm; 13C-NMR (101 MHz, CDCl3) δ 159.7
(C), 141.8 (C), 132.9 (C), 132.4 (C), 132.0 (CH), 130.7 (CH),
129.1 (CH), 128.0 (CH), 126.7 (CH), 125.3 (C), 125.1 (C), 122.5
(CH), 121.7 (CH), 79.6 (CH), 69.2 (CH2), 30.0 (CH2), 26.1(CH2)
ppm; IR ν 2967, 2869, 1584, 1495, 1255, 1054, 822, 767 cm−1;
LRMS (EI) m/z (%) = 283 (M+, 4), 254 (16), 240 ([M+ − C2H3O],
100), 227 (51), 213 (13) 177 (29); HRMS (EI) m/z calcd for
C15H11ClN 240.0580, found 240.0576.
3-Fluoro-6-(tetrahydrofuran-2-yl)phenanthridine (3oa).
Following the general procedure, but from 0.30 mmol of 1o,
compound 3oa was obtained after column chromatography
(hexane/EtOAc 96 : 4) as a brown oil (36 mg, 0.13 mmol, 45%):
Rf 0.20 (93 : 7 hexane/EtOAc);
1H-NMR (300 MHz, CDCl3) δ 8.54
(d, J = 8.3 Hz, 1H), 8.49 (H-1, dd, J = 9.1, 5.9 Hz, 1H), 8.43 (d,
J = 8.2 Hz, 1H), 7.87–7.78 (m, 2H), 7.67 (ddd, J = 8.3, 7.0,
1.2 Hz, 1H), 7.38 (H-2, ddd, J = 8.9, 8.1, 2.7 Hz, 1H), 5.76 (t, J =
6.9 Hz, 1H), 4.24–4.14 (m, 1H), 4.11–4.01 (m, 1H), 2.78–2.64
(m, 1H), 2.48–2.34 (m, 1H), 2.29–2.03 (m, 2H) ppm; 13C-NMR
(101 MHz, CDCl3) δ 162.7 (C-3, d,
1JC–F = 247.6 Hz), 160.9 (C),
144.7 (C-4a, d, 3JC–F = 11.9 Hz), 133.2 (C), 130.8 (CH), 127.2
(CH), 126.7 (CH), 124.5 (C, d, 4JC–F = 1.0 Hz), 123.9 (C-1, d,
3JC–F = 9.5 Hz), 122.3 (CH), 120.9 (d, JC–F = 2.1 Hz), 116.0 (CH,
d, 2JC–F = 23.7 Hz), 115.0 (CH, d,
2JC–F = 20.5 Hz), 79.5 (CH),
69.2 (CH2), 30.1 (CH2), 26.1(CH2) ppm; IR ν 2972, 2871, 1618,
1580, 1484, 1459, 1053, 764 cm−1; LRMS (EI) m/z (%) = 267
(M+, 5), 238 (15), 224 (100), 211 (55), 196 (17); HRMS (EI) m/z
calcd for C17H14FNO 267.1059, found 267.1048.
6-(1,4-Dioxan-2-yl)phenanthridine (3ab).13a Following the
general procedure, compound 3ab was obtained after column
chromatography (hexane/EtOAc 85 : 15–75 : 25) as a white solid
(69 mg, 0.26 mmol, 52%): Rf 0.25 (8 : 2 hexane/EtOAc).
1H-NMR (300 MHz, CDCl3) δ 8.66 (d, J = 8.3 Hz, 1H), 8.60–8.52
(m, 1H), 8.48–8.39 (m, 1H), 8.26–8.15 (m, 1H), 7.90–7.80 (m,
1H), 7.78–7.63 (m, 3H), 5.49 (p, J = 6.3 Hz, 1H), 4.34–4.29 (m,
2H), 4.21–4.06 (m, 2H), 3.99–3.88 (m, 2H) ppm; 13C-NMR
(75 MHz, CDCl3) δ 156.2 (C), 143.3 (C), 133.3 (C), 130.6 (CH),
130.6 (CH), 128.7 (CH), 127.5 (CH), 127.4 (CH), 126.2 (CH),
124.6 (C), 124.1 (C), 122.6 (CH), 122.0 (CH), 76.3 (CH), 70.2
(CH2), 67.9 (CH2), 66.7 (CH2) ppm; IR ν 2965, 2856, 1114,
10 856, 912, 759 cm−1; LRMS (EI) m/z (%) = 265 (M+, 4), 206
(100), 179 (24), 151 (12), 102 (5).
6-(Tetrahydro-2H-pyran-2-yl)phenanthridine (3ac).13c
Following the general procedure, compound 3ac was obtained
after column chromatography (hexane/EtOAc 98 : 2–9 : 1) as a
white solid (57 mg, 0.22 mmol, 43%): Rf 0.20 (95 : 5 hexane/
EtOAc); 1H-NMR (300 MHz, CDCl3) δ 8.62 (ddd, J = 8.2, 1.3,
0.6 Hz, 1H), 8.56–8.50 (m, 2H), 8.25–8.19 (m, 1H), 7.80 (ddd, J =
8.3, 7.0, 1.3 Hz, 1H), 7.74–7.66 (m, 2H), 7.65–7.57 (m, 1H), 5.20
(dd, J = 11.1, 2.2 Hz, 1H), 4.34–4.24 (m, 1H), 3.81 (td, J = 11.6,
2.4 Hz, 1H), 2.37–2.19 (m, 1H), 2.15–2.00 (m, 2H), 1.96–1.77
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(m, 2H), 1.74–1.63 (m, 1H) ppm; 13C-NMR (75 MHz, CDCl3)
δ 159.6 (C), 143.4 (C), 133.5 (C), 130.5 (CH), 130.3 (CH), 128.6
(CH), 127.1 (CH), 127.0 (CH), 126.8 (CH), 124.5 (C), 124.1 (C),
122.4 (CH), 121.9 (CH), 80.7 (CH), 69.6 (CH2), 30.6 (CH2), 26.1
(CH2), 24.0 (CH2) ppm; IR ν 3075, 2930, 2839, 1083, 1039, 754,
723 cm−1; LRMS (EI) m/z (%) = 262 (M+ − 1, 1), 235 (20), 206
(100), 193 (12).
6-(2-Isopropoxypropan-2-yl)phenanthridine (3ad).13c
Following the general procedure, compound 3ad was obtained
after column chromatography (100% hexane to hexane/EtOAc
98 : 2) as a brown pale oil (79 mg, 0.28 mmol, 57%): Rf 0.29
(100% hexane); 1H-NMR (300 MHz, CDCl3) δ 9.25 (ddd, J = 8.5,
1.4, 0.6 Hz, 1H), 8.70–8.64 (m, 1H), 8.57 (dd, J = 8.0, 1.6 Hz,
1H), 8.17–8.12 (m, 1H), 7.81 (ddd, J = 8.3, 7.0, 1.3 Hz, 1H),
7.77–7.61 (m, 3H), 3.75 (p, J = 6.1 Hz, 1H), 1.92 (s, 6H), 1.02 (d,
J = 6.1 Hz, 6H) ppm; 13C-NMR (101 MHz, CDCl3) δ 163.7 (C),
142.9 (C), 133.9 (C), 130.6 (CH), 130.3 (CH), 129.9 (CH), 128.5
(CH), 127.0 (CH), 126.1 (CH), 124.5 (C), 124.1 (C), 122.3 (CH),
121.9 (CH), 81.8 (C), 67.0 (CH), 29.1 (CH3), 24.8 (CH3);
IR ν 2983, 2933, 1578, 1379, 1162, 1110, 996, 760, 730 cm−1;
LRMS (EI) m/z (%) = 264 (M+, 0.2), 236 (18), 221 ([M+ − C5H7O],
100), 204 (34), 179 (54), 150 (18); HRMS (EI) m/z calcd for
C16H14N 220.1126, found 220.1128.
6-(1-Butoxybutyl)phenanthridine (3ae).13b Following the
general procedure, compound 3ae was obtained after column
chromatography (hexane/EtOAc 99 : 1–98 : 2) as a yellow oil
(123 mg, 0.40 mmol, 80%): Rf 0.65 (9 : 1 hexane/EtOAc);
1H-NMR (300 MHz, CDCl3) δ 8.94–8.89 (m, 1H), 8.69–8.64 (m,
1H), 8.57 (dd, J = 8.0, 1.6 Hz, 1H), 8.20–8.15 (m, 1H), 7.84
(ddd, J = 8.3, 7.0, 1.3 Hz, 1H), 7.77–7.62 (m, 3H), 4.98 (dd, J =
8.8, 5.4 Hz, 1H), 3.52–3.33 (m, 2H), 2.28–2.13 (m, 1H),
2.01–1.87 (m, 1H), 1.76–1.46 (m, 4H), 1.40–1.23 (m, 4H), 0.95
(t, J = 7.4 Hz, 3H), 0.83 (t, J = 7.3 Hz, 3H) ppm; 13C-NMR
(101 MHz, CDCl3) δ 161.9 (C), 143.4 (C), 133.5 (C), 130.5 (CH),
130.2 (CH), 128.7 (CH), 127.0 (CH), 124.5 (C), 124.1 (C), 122.4
(CH), 122.0 (CH), 86.5 (CH), 69.5 (CH2), 38.3 (CH2), 32.2 (CH2),
20.0 (CH2), 19.5 (CH2), 14.1 (CH3), 14.0 (CH3) ppm; IR ν 2957,
2932, 2870, 1759, 1459, 1092, 727 cm−1; LRMS (EI) m/z (%) =
265 (M+ − C3H6, 12), 250 (9), 235 (37), 206 (100), 151 (9).
6-(2-Methyltetrahydrofuran-2-yl)phenanthridine (3af ).
Following the general procedure, compound 3af was obtained
after column chromatography (hexane/EtOAc 99 : 1–9 : 1) as a
colorless oil (43 mg, 0.16 mmol, 33%): Rf 0.75 (9 : 1 hexane/
EtOAc); 1H-NMR (300 MHz, CDCl3) δ 9.14 (d, J = 8.4 Hz, 1H),
8.63 (d, J = 8.3 Hz, 1H), 8.53 (dd, J = 8.1, 1.5 Hz, 1H), 8.12 (d,
J = 8.0 Hz, 1H), 7.78 (ddd, J = 8.1, 6.6, 1.2 Hz, 1H), 7.72–7.58
(m, 3H), 4.14–4.03 (m, 1H), 3.80–3.69 (m, 1H), 3.66–3.56 (m,
1H), 2.10–1.88 (m, 3H), 1.83 (s, 3H) ppm; 13C-NMR (75 MHz,
CDCl3) δ 163.1, 142.9, 134.0, 130.4, 130.0, 129.3, 128.4, 126.9,
126.6, 124.4, 124.1, 122.4, 121.9, 88.7, 68.1, 37.4, 28.2,
25.2 ppm; IR ν 3065, 2970, 2930, 2872, 1570, 1097, 758 cm−1;
LRMS (EI) m/z (%) = 263 (M+, 18), 235 (48), 207 (86), 179 (55),
85 (100); HRMS (EI) calcd for C18H17NO 263.1310, found
263.1308.
6-(5-Methyltetrahydrofuran-2-yl)phenanthridine (3′af). From
the same reaction where compound 3af was obtained, and
after column chromatography (hexane/EtOAc 99 : 1–9 : 1),
isomer 3′af was isolated as a white solid (26 mg, 0.10 mmol,
21%) [trans/cis mixture in a 58 : 42 ratio (1H-NMR)]): Rf 0.75
(9 : 1 hexane/EtOAc); 1H-NMR (400 MHz, CDCl3) δ 8.62 (d, J =
8.3 Hz, 1.10H), 8.53 (d, J = 8.2 Hz, 1.51H), 8.46 (d, J = 7.9 Hz,
0.6H), 8.21–8.15 (m, 1H), 7.81 (ddt, J = 8.3, 7.0, 1.3 Hz, 1.09H),
7.75–7.59 (m, 3.58H), 5.91 (t, J = 6.9 Hz, 0.58H), 5.69 (t, J =
7.1 Hz, 0.42H), 4.53–4.43 (m, 0.64H), 4.37–4.27 (m, 0.47H),
2.91–2.73 (m, 1.06H), 2.52–2.42 (m, 0.62H), 2.42–2.27 (m,
1.02H), 2.27–2.14 (m, 0.44H), 1.87–1.67 (m, 1.5H), 1.39 (dd, J =
6.1, 3.3 Hz, 3H) ppm; 13C-NMR (75 MHz, CDCl3) δ 159.9 (C),
159.2 (C), 143.34 (C), 143.28 (C), 133.43 (C), 133.42 (C), 130.5
(CH), 130.4 (CH), 128.6 (CH), 128.6 (CH), 127.3 (CH), 127.3
(CH), 127.0 (CH), 126.9 (CH), 126.7 (CH), 125.1 (C), 124.9 (C),
124.3 (C), 124.2 (C), 122.5 (CH), 122.4 (CH), 122.0 (CH), 80.6
(CH), 79.2 (CH), 76.1 (CH2), 33.9 (CH2), 33.2 (CH2), 30.6 (CH2),
30.0 (CH2), 21.6 (CH3), 21.4 (CH3) ppm; IR ν 3074, 2971, 2929,
2877, 2861, 1583, 1444, 1073, 725 cm−1; LRMS (EI) m/z (%) =
263 (M+, 11), 220 (72), 208 (100), 179 (58); HRMS (EI): calcd for
C18H17NO 263.1310, found 263.1301.
6-(tert-Butoxymethyl)phenanthridine (3ag).13c Following the
general procedure, compound 3ag was obtained after column
chromatography (hexane/EtOAc 95 : 5–93 : 2) as a yellow solid
(53 mg, 0.20 mmol, 40%): Rf 0.24 (9 : 1 hexane/EtOAc);
1H-NMR (300 MHz, CDCl3) δ 8.61 (d, J = 8.3 Hz, 1H), 8.53 (td,
J = 8.1, 1.3 Hz, 2H), 8.17 (dd, J = 7.8, 1.4 Hz, 1H), 7.87–7.79 (m,
1H), 7.75–7.61 (m, 3H), 5.09 (s, 2H), 1.40 (s, 9H) ppm;
13C-NMR (75 MHz, CDCl3) δ 158.7 (C), 143.6 (C), 133.4 (C),
130.6 (CH), 130.2 (CH), 128.6 (CH), 127.6 (CH), 127.3 (CH),
127.1 (CH), 125.7 (C), 124.5 (C), 122.2 (CH), 122.0, 74.7 (CH),
66.9 (CH2), 27.9 (3CH3) ppm; IR ν 2974, 2932, 1719, 1364,
1145, 760 cm−1; LRMS (EI) m/z (%) = 265 ([(M + 1)+ − CH3], 1),
235 (37), 208 (100), 192 (48), 180 (51), 165 (25).
6-((Benzyloxy)(phenyl)methyl)phenanthridine (3ah).
Following the general procedure, compound 3ah was obtained
after column chromatography (hexane/EtOAc 99 : 1–98 : 2) as a
yellow solid (32 mg, 0.08 mmol, 17%): Rf 0.5 (9 : 1 hexane/
EtOAc); 1H-NMR (300 MHz, CDCl3) δ 8.65–8.55 (m, 3H),
8.30–8.25 (m, 1H), 7.81–7.66 (m, 3H), 7.57–7.43 (m, 3H),
7.39–7.25 (m, 7H), 7.24–7.19 (m, 1H), 6.27 (s, 1H), 4.73 (d, J =
11.7 Hz, 1H), 4.64 (d, J = 11.7 Hz, 1H) ppm; 13C-NMR
(101 MHz, CDCl3) δ 159.9 (C), 143.4 (C), 140.8 (C), 138.3 (C),
133.9 (C), 130.5 (CH), 130.5 (CH), 128.8 (CH), 128.4 (CH), 128.3
(CH), 128.0 (CH), 127.7 (CH), 127.4 (CH), 127.1 (CH), 126.3
(CH), 124.5 (C), 124.3 (C), 122.3 (CH), 122.1 (CH), 86.5 (CH),
71.7 (CH2) ppm; IR ν 3060, 3029, 2915, 2850, 1572, 1449, 1067,
722 cm−1. LRMS (EI-DIP) m/z (%) = 284 (M+ − C7H7, 52), 269
(100), 268 (52), 178 (16), 91 (32); HRMS (EI) calcd for
C27H21NO 375.1623, found 375.1605.
6-Benzylphenanthridine (3′ah).26 From the same reaction
where compound 3ah was obtained, and after column chrom-
atography (hexane/EtOAc 99 : 1–98 : 2), compound 3′ah was iso-
lated as a yellow solid (62 mg, 0.23 mmol, 46%): Rf 0.5
(9 : 1 hexane/EtOAc); 1H-NMR (300 MHz, CDCl3) δ 8.56 (br d,
J = 8.3 Hz, 1H), 8.51 (dd, J = 8.2, 1.4 Hz, 1H), 8.18 (ddd, J = 9.7,
8.1, 1.3 Hz, 2H), 7.72 (ddd, J = 8.2, 7.0, 1.4 Hz, 2H), 7.61 (ddd,
Organic & Biomolecular Chemistry Paper
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J = 8.3, 7.0, 1.4 Hz, 1H), 7.53 (ddd, J = 8.3, 7.0, 1.2 Hz, 1H),
7.33–7.28 (m, 2H), 7.26–7.10 (m, 4H), 4.74 (s, 2H) ppm;
13C-NMR (101 MHz, CDCl3) δ 160.2 (C), 143.8 (C), 139.2 (C),
133.3 (C), 130.4 (CH), 129.9 (CH), 128.7 (CH), 128.6 (2CH),
127.4 (CH), 127.1 (CH), 126.7 (CH), 126.4 (CH), 125.4 (C),
124.0 (C), 122.5 (CH), 122.0 (CH), 43.2 (CH2) ppm; IR ν 3062,
3025, 1684, 1581, 1362, 723 cm−1. LRMS (EI-DIP) m/z (%) = 269
(M+, 41), 268 (M+ − 1, 100), 254(6), 134 (11), 57 (6).
6-(1,3-Dihydroisobenzofuran-1-yl)phenanthridine (3ai).
Following the general procedure, compound 3ai was obtained
after column chromatography (hexane/EtOAc 99 : 1–98: 2) as a
yellow crystalline solid (52 mg, 0.17 mmol, 35%): Rf 0.4
(9 : 1 hexane/EtOAc); mp 120–121 °C (3 : 1 EtOAc/MeOH);
1H-NMR (400 MHz, CDCl3) δ 8.65 (br d, J = 8.3 Hz, 1H), 8.56
(dd, J = 8.1, 1.4 Hz, 1H), 8.25 (br d, J = 8.3 Hz, 1H), 8.17 (dd, J =
8.0, 1.2 Hz, 1H), 7.80 (s, 1H), 7.72 (ddd, J = 8.2, 7.0, 1.6 Hz,
1H), 7.66 (ddd, J = 8.4, 7.0, 1.5 Hz, 1H), 7.59 (ddd, J = 8.3, 7.0,
1.2 Hz, 1H), 7.41–7.37 (m, 1H), 7.35–7.30 (m, 1H), 7.23–7.13
(m, 2H), 6.97 (t, J = 2.5 Hz, 1H), 5.59 (dd, J = 12.3, 2.7 Hz, 1H),
5.42 (dd, J = 12.3, 2.0 Hz, 1H) ppm; 13C-NMR (101 MHz,
CDCl3) δ 158.8 (C), 143.4 (C), 140.9 (C), 139.2 (C), 133.9 (C),
130.7 (CH), 130.4 (CH), 128.7 (CH), 128.0 (CH), 127.5 (CH),
127.3 (CH), 127.3 (CH), 126.6 (CH), 124.6 (C), 124.4 (C), 122.8
(CH), 122.6 (CH), 122.0 (CH), 121.3(CH), 87.8 (CH), 73.8 (CH2)
ppm; IR ν 3074, 2851, 1572, 1027, 720 cm−1. LRMS (EI) m/z (%) =
297 (M+, 2), 268 (100), 251 (3), 119 (12); HRMS (EI) calcd for
C21H15NO 297.1154, found 297.1141.
6-(1,3,5-Trioxan-2-yl)phenanthridine (3aj). Following the
general procedure, compound 3aj was obtained after column
chromatography (100% hexane to hexane/EtOAc 8 : 2) as a
white solid (96 mg, 0.26 mmol, 52%): Rf 0.2 (9 : 1 hexane/
EtOAc); 1H-NMR (300 MHz, CDCl3) δ 9.10–9.04 (m, 1H), 8.64
(d, J = 8.3 Hz, 1H), 8.60–8.55 (m, 1H), 8.23–8.18 (m, 1H),
7.90–7.83 (m, 1H), 7.79–7.67 (m, 1H), 6.48 (s, 1H), 5.50 (q, J =
6.5 Hz, 4H) ppm; 13C-NMR (75 MHz, CDCl3) δ 153.6 (C),
142.8 (C), 134.0 (C), 131.0 (CH), 130.6 (CH), 128.9 (CH),
128.3 (CH), 128.1 (CH), 127.4 (CH), 125.0 (C), 123.7 (C),
122.2 (2CH), 106.1(CH), 94.2 (2CH2) ppm; IR ν 3037, 2884,
1418, 1199, 1100, 1047, 944, 750, 723 cm−1; LRMS (EI) m/z (%) =
267 (M+, 1), 208 (67), 179 (100), 151 (31); HRMS (EI) calcd for
C16H13NO3 267.0895, found 267.0879.
6-(Benzo[d][1,3]dioxol-2-yl)phenanthridine (3ak). Following
the general procedure, compound 3ak was obtained after
column chromatography (hexane/EtOAc 99 : 1–98 : 2) as a white
crystalline solid (90 mg, 0.3 mmol, 60%): Rf 0.49 (9 : 1 hexane/
EtOAc); mp 105–107 °C (MeOH); 1H-NMR (300 MHz, CDCl3)
δ 8.64 (br d, J = 8.3 Hz, 1H), 8.56 (dd, J = 8.0, 1.4 Hz, 1H),
8.30–8.21 (m, 2H), 7.82 (ddd, J = 8.4, 7.0, 1.3 Hz, 1H),
7.79–7.66 (m, 2H), 7.60 (ddd, J = 8.3, 7.0, 1.2 Hz, 1H), 7.43 (s,
1H), 7.04–6.91 (m, 4H) ppm; 13C-NMR (75 MHz, CDCl3)
δ 152.5 (C), 147.5 (2C), 142.9 (C), 133.9 (C), 130.9 (2CH),
129.0 (CH), 128.4 (CH), 127.7 (CH), 125.9 (CH), 125.0 (C),
123.8 (C), 122.6 (CH), 122.3 (2CH), 122.1 (CH), 112.2 (CH),
109.4 (2CH) ppm; IR ν 3078, 2909, 1479, 1338, 1229, 724 cm−1;
LRMS (EI) m/z (%) = 299 (M+, 2), 270 (100), 241 (9), 178 (7);
HRMS (EI) calcd for C20H13NO2 299.0946, found 299.0949.
Phenanthridine (4a).13a This compound was obtained as the
by-product of 3aa and of all compounds represented in
Scheme 3. After purification by column chromatography
(hexane/EtOAc 9 : 1), it was isolated as a white solid. Rf 0.25
(9 : 1 hexane/EtOAc); 1H-NMR (300 MHz, CDCl3) δ 9.28 (s, 1H),
8.63–8.54 (m, 1H), 8.20 (dd, J = 8.1, 1.3 Hz, 1H), 8.03 (br d, J =
7.9 Hz, 1H), 7.84 (ddd, J = 8.4, 7.1, 1.4 Hz, 1H), 7.78–7.63 (m,
2H) ppm; 13C-NMR (75 MHz, CDCl3) δ 153.7 (CH), 144.6 (C),
132.7 (C), 131.1 (CH), 130.3 (CH), 128.9 (CH), 128.8 (CH), 127.6
(CH), 127.2 (CH), 126.5 (C), 124.2 (C), 122.3 (CH), 122.0 (CH)
ppm; IR ν 2924, 2851, 1457, 1245, 890, 745 cm−1; LRMS (EI)
m/z (%) = 179 (M+, 100), 151 (13), 76(100), 179 (8).
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